10x Genomics, Inc. Class A Common Stock (TXG) is a publicly traded Healthcare sector company. As of July 15, 2026, TXG trades at $45.97 with a market cap of $5.30B and a P/E ratio of -266.26. TXG moved +0.39% today. Year to date, TXG is +180.75%; over the trailing twelve months it is +267.20%. Its 52-week range spans $6.78 to $45.82. Analyst consensus is buy with an average price target of $33.00. Rallies surfaces TXG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for TXG, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $45.97 |
| Market Cap | $5.30B |
| P/E Ratio | -266.26 |
| EPS | $-0.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $45.82 |
| 52-Week Low | $6.78 |
| Volume | 2.19K |
| Avg Volume | 0 |
| Revenue (TTM) | $638.78M |
| Net Income | $-22.66M |
| Gross Margin | 69.60% |
10 analysts cover TXG: 0 strong buy, 3 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $33.00.